Man Group Files Form 8.3 Disclosure for RHI Magnesita
Man Group filed a Takeover Code Form 8.3 disclosure concerning RHI Magnesita. The supplied text does not provide the disclosed position details.
Related stories
CG Oncology Reports Third-Quarter 2026 Financial Results and Business Updates
CG Oncology reported results for the quarter ended September 30, 2026. The company said it expects to share PIVOT-006 topline data this month.
M impact | EQUITY | Nov 06, 2026, 01:33 PM UTC
CG Oncology Q3 Net Loss Widens on Higher R&D Costs
M impact | EQUITY | Nov 06, 2026, 01:25 PM UTC
Tredegar Reports Third-Quarter 2026 Results
Tredegar reported financial results for the period ended September 30, 2026.
M impact | EQUITY | Nov 06, 2026, 01:23 PM UTC
Aura Minerals Q3 Revenue Beats Estimates on Record Production
M impact | EQUITY | Nov 06, 2026, 01:21 PM UTC
Aura Minerals Q3 Revenue Rose 56% to $386.0 Million
Q3 2026 revenue rose 56% year over year to $386.0 million. Adjusted EBITDA also rose 56% to $236.9 million; nine-month revenue was $1,104.6 million, up 84%, and net income was $447
M impact | EQUITY | Nov 06, 2026, 01:16 PM UTC
Aura Minerals Announces Q3 and Nine-Month 2026 Results
Aura Minerals says it filed its audited consolidated financial statements and earnings release for the periods ended in Q3 and the first nine months of 2026.
M impact | EQUITY | Nov 06, 2026, 01:16 PM UTC